NAD-蛋白去乙酰化酶Sirtuin1通路调控CD8 T细胞记忆及耗竭分化的机制研究
批准号:
81971466
项目类别:
面上项目
资助金额:
56.0 万元
负责人:
张连军
依托单位:
学科分类:
免疫调节异常
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
张连军
中文摘要
CD8 T细胞记忆形成和功能耗竭在代谢及表观遗传学层次受到严格调控。NAD是细胞能量代谢的重要调控因子,对维持线粒体活性及氧化还原稳态至关重要。NAD依赖的蛋白去乙酰化酶Sirtuin1(SIRT1)参与CD4 T细胞分化。但NAD-SIRT1在CD8 T细胞记忆形成及耗竭中作用未知。我们近期研究发现:记忆CD8 T细胞呈现高水平NAD,NAD处理促进T细胞记忆表型形成及增强线粒体备用呼吸能力等代谢特征。我们通过构建的CD8 T细胞特异SIRT1敲除小鼠证明,SIRT1参与调控CD8 T细胞记忆形成及耗竭。本项目将在此工作基础上,联合李斯特菌急性感染模型及小鼠肿瘤模型,系统研究NAD-SIRT1在CD8 T细胞效应/记忆分化及耗竭过程中的作用。应用组学、基因编辑、生化等技术深入探讨相关的线粒体代谢及表观遗传学调控机制。本研究将对提高CD8 T细胞抗感染及肿瘤提供重要理论依据。
英文摘要
Both CD8 T cell memory formation and exhaustion are tightly controlled at the metabolic and epigenetic level. NAD is a co-factor of many key enzymes of cellular metabolism and important regulator of mitochondrial activity and redox reactions. Sirtuin1(SIRT1) is NAD dependent protein deacetylase and regulates CD4 T cell differentiation. However, it remains unclear whether and how does NAD-SIRT1 signaling axis regulate CD8 T cell exhaustion and memory formation. Interestingly, our preliminary data suggest that memory CD8 T cells harbor higher cellular NAD and lower surface CD38 expression as compared to effector cells. Boosting cellular NAD during CD8 T cell priming promotes memory phenotype and enhanced mitochondrial spare respiratory capacity, which is the cardinal feature of memory T cell metabolism. Furthermore, with CD8 T cell specific SIRT1 KO mice, we show that SIRT1 is critically involved in CD8 T cell differentiation and functional exhaustion. In the present study, with the listeria-OVA infection model and mouse melanoma model, we aim to understand the role of NAD and SIRT1 in CD8 T cell effector, memory or exhaustion and uncover the metabolic or epigenetic basis for this regulation. Our study will provide important evidence for improving CD8 T cell immunity against infections and cancer.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
--
发表时间:
2020
期刊:
Trends in Cancer
影响因子:
18.4
作者:
[Qianqian Duan, Hualing Zhang, Junnian Zheng, Lianjun Zhang]
通讯作者:
Lianjun Zhang
DOI:
10.1038/s41423-020-0365-3
发表时间:
2021-07
期刊:
Cellular & molecular immunology
影响因子:
24.1
作者:
[Dumauthioz N, Tschumi B, Wenes M, Marti B, Wang H, Franco F, Li W, Lopez-Mejia IC, Fajas L, Ho PC, Donda A, Romero P, Zhang L]
通讯作者:
Zhang L
Elevated CD38 expression characterizes impaired CD8+ T cell immune response in metastatic pleural effusions.
CD38 表达升高是转移性胸腔积液中 CD8 T 细胞免疫反应受损的特征。
DOI:
10.1016/j.imlet.2022.04.003
发表时间:
2022
期刊:
Immunology letters
影响因子:
4.4
作者:
[Yaoxin Zhang, Wenhui Li, Kaili Ma, Jiawei Zhai, Yu, Lianjun Zhang, Cheng Chen]
通讯作者:
Cheng Chen
DOI:
--
发表时间:
2021
期刊:
Cancer Immunology Research
影响因子:
10.1
作者:
[Chenfeng Han, Minmin Ge, Ping-Chih Ho, Lianjun Zhang]
通讯作者:
Lianjun Zhang
DOI:
10.1038/s42255-022-00730-6
发表时间:
2023-02
期刊:
NATURE METABOLISM
影响因子:
20.8
作者:
[Cheng, Hongcheng, Qiu, Yajing, Xu, Yue, Chen, Li, Ma, Kaili, Tao, Mengyuan, Frankiw, Luke, Yin, Hongli, Xie, Ermei, Pan, Xiaoli, Du, Jing, Wang, Zhe, Zhu, Wenjie, Chen, Lu, Zhang, Lianjun, Li, Guideng]
通讯作者:
Li, Guideng
共 15 条
内质网相关降解关键因子Sel1L调控CD8+T细胞稳态及免疫应答机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:53万元
-
批准年份:2022
-
负责人:张连军
-
依托单位:
国内基金
海外基金